U.S. RESEARCH ROUNDUP-Athira pharma, Lowe's Companies, P&G

FTAI Aviation

19/09/2024 08:26

Sept 19 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several
U.S.-listed companies, including Athira pharma, Lowe's Companies and P&G on Thursday. 
    
  HIGHLIGHTS   
         
                 * Athira pharma Inc  ATHA.O : Mizuho cuts to neutral from outperform
 
                 * Five Below Inc  FIVE.O : JP Morgan cuts to underweight from neutral
 
                 * Lowe's Companies Inc  LOW.N : TD Cowen raises target price to $265 from $240
 
                 * P&G  PG.N : JP Morgan raises target price to $186 from $179
 
                 * SS&C Technologies Holdings Inc  SSNC.O : RBC raises target price to $86 from $75
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in
alphabetical order.   
  
                 * 4D Molecular Therapeutics Inc  FDMT.O : Leerink Partners cuts PT to $36 from $40
 
                 * Abbott  ABT.N : Piper Sandler initiates coverage with overweight rating; price target $131
 
                 * Applied Therapeutics Inc  APLT.O : Leerink Partners raises target price to $14 from $11
 
                 * Athira pharma Inc  ATHA.O : Mizuho cuts target price to $0.5 from $5
 
                 * Athira pharma Inc  ATHA.O : Mizuho cuts to neutral from outperform
 
                 * Carmax Inc  KMX.N : JP Morgan raises target price to $65 from $55
 
                 * Charter Communications Inc  CHTR.O : RBC initiates coverage with sector perform rating
 
                 * Charter Communications Inc  CHTR.O : RBC initiates coverage with price target $345
 
                 * Driven Brands Holdings Inc  DRVN.O : Canaccord Genuity raises PT to $20 from $19
 
                 * Five Below Inc  FIVE.O : JP Morgan cuts to underweight from neutral
 
                 * Five Below Inc  FIVE.O : JP Morgan raises target price to $95 from $89
 
                 * FTAI Aviation Ltd  FTAI.O : RBC raises target price to $143 from $120
 
                 * General Mills  GIS.N : Jefferies raises target price to $73 from $69
 
                 * Getty Realty Corp  GTY.N : JP Morgan raises target price to $33 from $31
 
                 * Halozyme Therapeutics Inc  HALO.O : JP Morgan cuts to neutral from overweight
 
                 * Halozyme Therapeutics Inc  HALO.O : JP Morgan raises target price to $57 from $52
 
                 * Healthequity Inc  HQY.O : RBC raises target price to $100 from $92
 
                 * Lowe's Companies Inc  LOW.N : TD Cowen raises target price to $265 from $240
 
                 * Micron Technology Inc  MU.O : TD Cowen cuts target price to $115 from $160
 
                 * Nextera Energy  NEE.N : HSBC raises target price to $95 from $88
 
                 * Nextera Energy  NEE.N : Jefferies initiates coverage with hold rating; price target $87
 
                 * Nextera Energy  NEP.N : Jefferies initiates coverage with buy rating
 
                 * Nextera Energy  NEP.N : Jefferies initiates coverage with price target $28
 
                 * P&G  PG.N : JP Morgan raises target price to $186 from $179
 
                 * Progyny Inc  PGNY.O : JP Morgan cuts target price to $22 from $31
 
                 * Progyny Inc  PGNY.O : Leerink Partners cuts target price to $21 from $25
 
                 * Rayonier Advanced Materials Inc  RYAM.N : RBC raises target price to $10 from $9
 
                 * Robinhood Markets Inc  HOOD.O : Piper Sandler raises target price to $27 from $23
 
                 * SS&C Technologies Holdings Inc  SSNC.O : RBC raises target price to $86 from $75
 
                 * T-Mobile  TMUS.O : JP Morgan raises target price to $230 from $220
 
                 * T-Mobile  TMUS.O : Scotiabank raises target price to $215.5 from $197
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))